Sort   by:  
 Page size 
UnknownCombination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer.
Not available
S-EPMC11486564 | biostudies-literature
UnknownAntibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.
Not available
S-EPMC5245175 | biostudies-literature
UnknownDetermination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform.
Not available
S-EPMC5479826 | biostudies-literature
UnknownNanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation.
Not available
S-EPMC4950352 | biostudies-literature
UnknownEngineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.
Not available
S-EPMC7932755 | biostudies-literature
UnknownCovalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model.
Not available
S-EPMC6823631 | biostudies-literature
UnknownGlycome and transcriptome regulation of vasculogenesis.
Not available
S-EPMC4001715 | biostudies-literature
UnknownIn vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma.
Not available
S-EPMC7607744 | biostudies-literature
UnknownFatty acid synthase is a novel therapeutic target in multiple myeloma.
Not available
S-EPMC2408665 | biostudies-literature
UnknownSNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.
Not available
S-EPMC2630270 | biostudies-literature
Sort   by:  
 Page size